Trials / Completed
CompletedNCT01843556
A Phase 1 Study of E2022 Tape Formulation for Different Application Sites and Intervals in Japanese Healthy Elderly Males
A Phase 1 Study of E2022 Tape Formulation for Different Application Sites and Intervals
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Eisai Co., Ltd. · Industry
- Sex
- Male
- Age
- 65 Years
- Healthy volunteers
- Accepted
Summary
A phase 1 study of E2022 tape formulation in healthy elderly males to evaluate the safety and pharmacokinetics.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | E2022 Tape Formulation | E2022 tape formulation applied to different application sites and at different intervals in Japanese healthy elderly males |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2013-04-01
- Completion
- 2013-06-01
- First posted
- 2013-04-30
- Last updated
- 2023-06-18
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01843556. Inclusion in this directory is not an endorsement.